Mysulin R

Insulin Human (rDNA) Regular

Mysulin-R 40 IU injection: Each ml solution contains Insulin Human (rDNA) USP 40 IU (equivalent to 1.388 mg) as Soluble Insulin Human (Regular).

Mysulin-R 100 IU injection: Each ml solution contains Insulin Human (rDNA) USP 100 IU (equivalent to 3.47 mg) as Soluble Insulin Human (Regular).

Indications :It is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 1 and type 2 diabetes mellitus.

Dosage :The dosage and administration time of the insulin are different due to the individual differences of each patient. It should be given subcutaneously approximately 15-30 minutes before a meal. Theaverage range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg/day. However, in prepubertal children it usually varies from 0.7 to 1 IU/kg/day. In situations of insulin resistance, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for

patients with diabetes are often lower, e.g., 0.3 to 0.6 IU/kg/day.An injection should be followed by a meal or snack containing carbohydrates within 30 minutes.The preparations are administered subctaneously in the thigh or

abdominal wall. A subcutaneous injection into the abdominal wall results in a faster absorption than from other injection sites.Iinsulin suspensions are never to be administered intravenously. Or, as directed by the registered physician.

Use in pregnancy and lactation :There are no restrictions on the treatment of diabetes with insulin during pregnancy, as insulin does not pass the placental barrier. Insulin treatment of the nursing mother presents no risk to the baby.

Mysulin-R 40IU: Each box contains 10ml glass vial.

Mysulin-R 100IU: Each box contains 10ml glass vial

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.